WallStreetZenWallStreetZen

How to Buy Chemours Co Stock

Chemours Co

Chemours Co is a specialty chemical company located in Delaware, United States, which is part of the Basic Materials sector, and is traded under the ticker CC on the NYSE exchange.

Chemours Co stock last closed at $29.16, up 1.25% from the previous day, and has decreased 7.84% in one year. It has underperformed other stocks in the Specialty Chemicals industry by 0.03 percentage points. Chemours Co stock is currently +23.66% from its 52-week low of $23.58, and -35.12% from its 52-week high of $44.95.

At the moment, there are 148.34M shares of CC outstanding. The market value of CC is $4.33B. In the last 24 hours, 904,605 CC shares were traded.

How to Buy Chemours Co Stock

Not sure how to invest in Chemours Co stock? Here's how.
  1. Figure out where to buy Chemours Co stock: You need to pick an online brokerage, but don't worry - we've analyzed dozens of online stock brokerages and apps to help you figure out where to buy Chemours Co stock.
  2. Create your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
  3. Deposit funds into your brokerage account: Pick your method of payment and add your details.
  4. Analyze Chemours Co stock: The Chemours Co ticker symbol is CC. Is Chemours Co stock a good investment? Should you buy shares of CC? How do CC's underlying business fundamentals look? Do top analysts think Chemours Co is a good buy? Why has CC's stock price moved recently? (Hint: Our stock market analysis website can help you decide if CC is a good stock to buy).
  5. Place your CC trade: Decide if you will purchase CC shares at the current market price or use a limit order to purchase CC stock at a given price.
  6. Watch your investment in CC: Create a watchlist to monitor your position in Chemours Co shares.

Step 1: Figure out where to buy Chemours Co stock

You need an online brokerage account in order to access the NYSE market and buy CC shares.

A brokerage account allows you to buy and sell a variety of financial instruments, such as stocks, bonds, mutual funds, and ETFs.

Our preferred brokerage: eToro

We believe that eToro is the best stock brokerage. Here's why:

  • Invest in stocks with zero commissions: Invest without paying trading commissions.
  • Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
  • Access to global financial markets: From Tech to Financial Services, New York to Hong Kong — you can fill your portfolio with stocks from the world's leading stock exchanges.
  • Social investing: eToro has a community of more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of other investors.
  • Security: eToro is a regulated and licensed fintech leader.
  • Buy other financial assets: Such as ETFs and cryptocurrencies.

Get $10 towards your share purchase by creating an account with eToro now.

Open eToro Account

Step 2: Create your brokerage account

Now that you've picked the best brokerage, you'll need to fill out some personal info so you are able to invest in CC today.

How to Create a New Account on eToro

  1. Click here to get started.
  2. Input your personal info to create a new brokerage account.
  1. Send your info by hitting the "Create Account" button.
Get started with eToro today

Step 3: Deposit funds into your brokerage account

Now that you've created your account on app for stock market, you need to deposit funds:

Check out this video walkthrough for more details transferring money into your new brokerage account.

Get started with eToro today

Step 4: Analyze Chemours Co stock

Once you have figured out the best place to buy Chemours Co stock, it's crucial to research their stock prior to buying, so you truly wrap your head around the risk as well as the upside.

Chemours Co Numbers

CC Price
$29.16
1w %
0.14%
1y %
-7.84%
5y %
-37.45%
P/E
7.84x
P/B
3.91x
P/S
0.64x
PEG
N/A
Revenue
$6.79B
Earnings
$578.00M
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
$4.33B
Next Earnings
May 1, 2023
Next Dividend
N/A

CC Fundamentals

WallStreetZen was built to help part-time investors perform more in-depth fundamental analysis.

You can see all of the due diligence checks on CC's stock page.

Is CC stock undervalued?

Investors use many financial metrics, analyses, models, and charts to gauge CC's intrinsic value.

Using relative valuations ratios:

  • CC may be undervalued based on its P/E ratio of 7.84x, relative to Specialty Chemicals industry P/E ratio of 25.61x
  • CC may be overvalued based on its P/B ratio of 3.91x, relative to Specialty Chemicals industry P/B ratio of 3.51x

You can do additional valuation research on CC's stock here.

A look at CC Cashflows and Balance Sheet

Pros:

  • Total CC debt is lower than 5 years ago, relative to shareholder equity.
  • CC earnings of $904.00M is not sufficient to cover its interest payments.
  • There are more short-term assets than short-term liabilities on the CC balance sheet.

Cons:

  • CC's operating cash flow of $754.00M allows it to safely service it's debt of $3.81B.
  • CC has a relatively high debt to equity ratio of 5.9.
  • There are more long-term liabilities than short-term assets on the CC balance sheet.
  • CC profit margin has gone down from 9.6% to 8.5% in the past year.

Is Chemours Co stock a Buy, Hold, or Sell, according to Wall Street analysts?

Out of 9 Equities analysts who give ratings on CC, the consensus analyst rating on CC is a Buy

Please note that analyst forecasts are not recommendations, nor are they financial advice.

Most Recent CC Analyst Upgrades/Downgrades

Duffy Fischer, a top 20% analyst from Goldman Sachs maintains CC with a hold rating and raises their CC price target from $34.00 to $38.00, on Feb 14, 2023.

PJ Juvekar, a top 9% analyst from Citigroup maintains CC with a hold rating and raises their CC price target from $33.00 to $35.00, on Feb 13, 2023.

Arun Viswanathan, a bottom 10% analyst from RBC Capital maintains CC with a hold rating and raises their CC price target from $33.00 to $36.00, on Feb 13, 2023.

John Roberts, a top 3% analyst from Credit Suisse maintains CC with a sell rating and raises their CC price target from $24.00 to $27.00, on Feb 10, 2023.

Joshua Spector, a top 20% analyst from UBS upgrades CC to a strong buy rating and raises their CC price target from $31.00 to $43.00, on Jan 24, 2023.

You can dive deeper into what analysts are projecting on the Chemours Co stock forecast page.

CC Momentum

SMA10
29.23
SMA20
31.61
SMA50
33.35
SMA100
32.28
SMA200
32.16
MACD
-1.44
MACD Signal
-1.22
MACD Histogram
-0.22
RSI
38.76
Stochastic %K
13.68
Stochastic %D
13.67
StochRSI %K
35.68
StochRSI %D
27.49

CC Growth Numbers

Last year, CC earnings were $578.00M. Over the last five year, CC's earnings have grown by -1.64% per year. This was slower than the Specialty Chemicals industry average of 21.04%.

Last year, CC revenue was $6.79B. In the last five year, CC's revenue has gone up by 1.9% per year. This was slower than the Specialty Chemicals industry average of 15.37%.

Dig into CC's earnings and revenue performance here.

What are CC executives and large shareholders up to?

In the last year, executives and large shareholders at CC have sold more shares than they have bought.

Alisha Bellezza, President Thermal Spec Solns of CC, was the latest CC insider to sell. They sold $210,549.92 worth of CC shares on Mar 6, 2023.

Learn more about who owns CC shares here.

Can I rely on CC as an income stream?

Chemours Co pays a dividend of 3.43%, compared to the Specialty Chemicals industry's average dividend yield of 2.4%. If you owned $1,000 of CC stock, you would have been paid $34.29 in the past year.

Chemours Co dividend payments have not consistently grown over the past 8 years and have not remained stable.

Find more data about Chemours Co dividend yield and history here.

What others are saying about CC

One of the primary reasons eToro is our favorite brokerage is because of its social trading community.

Click below to find out what other investors have to say.

Step 5: Place your CC trade

There are two main options:

  • Market order: A market order is an order to buy or sell a security at the best possible price.
    Market orders are mostly fine.
  • Limit order: A limit order lets you buy or sell a security at a specific price (or better).
    If you want to make sure you're buying or selling at a given dollar amount limit, place a limit order.

Hit the Open Trade button and your broker will place the order.

If you need more help buying stocks on eToro, click the helpful video below:

Open eToro Account

Step 6: Watch your investment in CC

Now that you own some CC stock, you'll want to keep up with your new shares.

Create a watchlist to keep track of your CC stock.

CC Feed

How to Buy Stock in Chemours Co

To summarize, here are the 6 steps you need to take to buy Chemours Co stock right now:

  1. Figure out where to buy Chemours Co stock
  2. Create your brokerage account
  3. Deposit funds into your brokerage account
  4. Analyze Chemours Co stock
  5. Place your CC trade
  6. Watch your investment in CC

If you are looking for a place to buy stocks, eToro is our favorite venue.

Get Started with eToro Today

If you would like to get the latest scoop on your investment in Chemours Co, hit the button below to create your watchlist.

NYSE: CC
$29.16+0.36 (+1.25%)
Updated Mar 27, 2023
Open eToro Account
NYSE: CC
$29.16+0.36 (+1.25%)
Updated Mar 27, 2023
Open eToro Account

FAQ

How much does it cost to buy one Chemours Co share?

As of Mar 27, 2023, it costs $29.16 to buy one share of Chemours Co stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.343 shares of CC.

Get Started with eToro Today

Is now a good time to buy Chemours Co stock?

According to 9 Wall Street analysts who monitor Chemours Co, their consensus recommendation is to buy Chemours Co stock.

What is the best way to buy Chemours Co stock?

One way to place an order for Chemours Co stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.